HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute respiratory failure due to Pneumocystis carinii pneumonia: clinical, radiographic, and pathologic course.

Abstract
The clinical, radiographic, and pathologic correlates of acute respiratory failure due to Pneumocystis carinii pneumonia were studied in 12 renal transplant patients treated with cyclosporin (CS) and prednisone. Six patients required only supplemental oxygen, while the other six patients developed the adult respiratory distress syndrome (ARDS) requiring prolonged mechanical ventilation despite similar predisposing factors and prompt initiation of therapy. Ten (83%) patients survived. Increased frequency of human leukocyte antigen (HLA) DR6 was noted in six of the 11 patients tested. The resolution of radiographic infiltrates was significantly slower in ARDS patients; however, there was no apparent difference in the severity of early alveolar damage between the two groups. There was also no association between the development of ARDS due to P. carinii pneumonia and the mean daily dose of CS and prednisone, the presence of cytomegalovirus infection or pneumonia, HLA-DR6 antigen, or initial hypoxemia.
AuthorsA F Suffredini, M J Tobin, C P Wajszczuk, B S Slasky, R L Peel, B J Carpenter, M Ho, A Grenvik
JournalCritical care medicine (Crit Care Med) Vol. 13 Issue 4 Pg. 237-43 (Apr 1985) ISSN: 0090-3493 [Print] United States
PMID3884275 (Publication Type: Journal Article)
Topics
  • Acute Disease
  • Adult
  • Aged
  • Female
  • Humans
  • Immunosuppression Therapy
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Pneumonia, Pneumocystis (diagnostic imaging, pathology, physiopathology)
  • Pulmonary Alveoli (microbiology, pathology)
  • Radiography
  • Respiration, Artificial
  • Respiratory Distress Syndrome (diagnostic imaging, etiology, pathology)
  • Respiratory Insufficiency (diagnostic imaging, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: